A Review of Recent Innovations in the Treatment of Low Sexual Desire

Purpose of Review: To review approaches since 2013 of the clinical management of low sexual desire. Recent Findings: The history of the treatment of the sexual dysfunctions has emphasized that the couple should be the target of treatment. Recent attempts at treatment of low desire have focused on women rather than couples. Men with low desire or couples with sexual desire discrepancies are generally overlooked. Among pharmaceutical interventions, only flibanserin (Addyi) has been approved by the FDA for treatment of low desire in premenopausal women. Other treatments for low desire in women include bibliotherapy and mindfulness. Models of couples therapy tend to focus on sexual desire discrepancies or enhancing the quality of erotic intimacy within relationships rather than treating the identified patient. Summary: There is a lack of consensus as to how to conceptualize and how to treat low sexual desire in men, women, or couples and on whether to target the identified patient or the relationship. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.